ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Epigenetics >HDAC inhibitors >CAY10683 (SantacruzaMate A)

CAY10683 (SantacruzaMate A)

CAY10683 (SantacruzaMate A) Suppliers list
Company Name: Shanghai Send Pharmaceutical Technology Co., Ltd.  Gold
Tel: 021-58088081 18317173152
Email: Hailey@shsendpharm.com
Company Name: Shanghai Beckham Medical Technology Co., Ltd  Gold
Tel: 13816613772
Email: huahero21@sina.com
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Tel:
Email: sales@boylechem.com
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Company Name: MedChemexpress LLC  
Tel: 021-58955995
Email: sales@medchemexpress.cn

CAY10683 (SantacruzaMate A) manufacturers

  • Santacruzamate A
  • Santacruzamate A pictures
  • $10.00
  • 2026-09-18
  • CAS:1477949-42-0
  • Min. Order: 1ASSAYS
  • Purity: 99%
  • Supply Ability: 1 ton
  • SantacruzaMate A
  • SantacruzaMate A pictures
  • $30.00
  • 2026-07-17
  • CAS:1477949-42-0
  • Purity: 98.27%
  • Supply Ability: 10g
CAY10683 (SantacruzaMate A) Basic information
Background
Product Name:CAY10683 (SantacruzaMate A)
Synonyms:CAY10683 (SantacruzaMate A);ETHYL 4-OXO-4-(PHENETHYLAMINO)BUTYLCARBAMATE;N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid ethyl ester;Santacruzamate A (CAY10683);SantacruzaMate A;CAY1083;Carbamic acid, N-[4-oxo-4-[(2-phenylethyl)amino]butyl]-, ethyl ester;Santacruzamate A, >98%
CAS:1477949-42-0
MF:C15H22N2O3
MW:278.35
EINECS:202-303-5
Product Categories:Inhibitors
Mol File:1477949-42-0.mol
CAY10683 (SantacruzaMate A) Structure
CAY10683 (SantacruzaMate A) Chemical Properties
Boiling point 508.1±43.0 °C(Predicted)
density 1.087±0.06 g/cm3(Predicted)
storage temp. -20°
solubility Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 20 mg/ml).
form solid
pka12.68±0.46(Predicted)
color Off-white
Stability:Stable for 2 years from date of purchse as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 2 months.
InChI1S/C15H22N2O3/c1-2-20-15(19)17-11-6-9-14(18)16-12-10-13-7-4-3-5-8-13/h3-5,7-8H,2,6,9-12H2,1H3,(H,16,18)(H,17,19)
InChIKeyHTOYBIILVCHURC-UHFFFAOYSA-N
SMILESO=C(CCCNC(OCC)=O)NCCC1=CC=CC=C1
Safety Information
WGK Germany WGK 3
Storage Class11 - Combustible Solids
MSDS Information
CAY10683 (SantacruzaMate A) Usage And Synthesis
DescriptionSantacruzamate A (1477949-42-0) is a highly potent and selective inhibitor of HDAC2 isolated from the Panamanian marine cyanobacteriumcf. Symploca(IC50=0.119 and 434 nM for HDAC2 and HDAC6 respectively).1Induces apoptosis and cancer cell death only in combination with other HDAC1 inhibitors.2Potential therapeutic agent for breast cancer.3Attenuates Aβ fragment (Aβ25-35)-induced toxicity in PC12 cells by enhancing ER stress tolerance.4Ameliorates Alzheimer’s disease-like pathology in mouse models.4
UsesSantacruzamate A is a natural product isolated from Panamanian marine cyanobacterium Symploca sp; a histone deacetylases (HDACs) inhibitor; an attractive targeted therapy against breast cancer in women.
DefinitionChEBI: Santacruzamate A is an organooxygen compound and an organonitrogen compound. It is functionally related to a gamma-amino acid.
IC 50HDAC2: 119 pM (IC50); HDAC6: 434 nM (IC50)
storageStore at -20°C
BackgroundSantacruzamate A is a cytotoxin isolated from the Panamanian marine cyanobacterium cf. Symploca sp., and is a highly selective inhibitor of histone deacetylases, specifically HDAC2 and HDAC6. This small molecule has been shown to induce apoptosis via transcriptional inhibition of HDAC2, resulting in an increase of p21 Waf1/Cip1 and p19INK4d expression when combined with an HDAC1 inhibitor. Santacruzamate A has also demonstrated the ability to attenuate amyloid-β protein fragment-induced toxicity through enhancing endoplasmic reticulum stress tolerance in mice. Additionally, HDAC2 has been recognized as a host immune response to the influenza A virus and several other viruses, making HDAC inhibitors important compounds to study in relation to viral diseases.
References[1] CHRISTOPHER M. PAVLIK. Santacruzamate A, a Potent and Selective Histone Deacetylase Inhibitor from the Panamanian Marine Cyanobacterium cf. Symploca sp.[J]. Journal of Natural Products , 2013, 76 11: 2026-2033. DOI:10.1021/np400198r
[2] HENGYU ZHOU. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1/Cip1 and p19INK4d upregulation in hepatocellular carcinoma[J]. Cell Proliferation, 2018, 51 3. DOI:10.1111/cpr.12447
[3] C. DAMASKOS. Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.[J]. Anticancer research, 2017, 37 1: 35-46. DOI:10.21873/anticanres.11286
[4] LEI CHEN. Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro.[J]. ACS Applied Energy Materials, 2019: 61. DOI:10.3389/fncel.2019.00061
CAY10683 (SantacruzaMate A) Preparation Products And Raw materials
Tag:CAY10683 (SantacruzaMate A)(1477949-42-0) Related Product Information
Methoprene acid Y-27632 dihydrochloride Fruquintinib DO264 Dequalinium chloride Axitinib PFI3 VE 822 Ruxolitinib Olaparib